CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Hematologic Malignancies » Leukemia and Lymphoma

ONCOLOGY. Vol. 12 No. 1
 

Cocaine Use May Double the Risk of Developing NHL

January 1, 1998

Researchers found that men who use cocaine are twice as likely as abstainers to develop intermediate- or high-grade non-Hodgkin’s lymphoma (NHL). For those who use cocaine more frequently, ie, on at least nine occasions, the risk is more than triple what nonusers face, says Rebecca Nelson, a doctoral student in the preventive medicine department at the University of Southern California (USC) School of Medicine, in an article published recently in the British Journal of Cancer.

Coauthors of the study were USC School of Medicine faculty members Leslie Bernstein, PhD, professor of preventive medicine; Alexandra Levine, MD, professor and chief of hematology; and Gary Marks, MD, associated professor of preventive medicine.

In 1994, 45,000 people in the US were diagnosed with NHL; roughly half of all NHL patients survive 5 years or more.

Case-Control Study

Researchers studied 378 Los Angeles residents diagnosed with NHL. The patients, 18 to 75 years old, were matched with healthy controls of the same age, ethnicity, gender, and social background. All patients and controls tested negative for the AIDS virus, HIV-1. Researchers asked patients and controls about their use of tobacco, alcohol(Drug information on alcohol), and 10 recreational drugs, including cocaine, marijuana, heroin, amphetamines, barbiturates, Quaaludes, LSD, PCP, “magic mushrooms,” and “poppers,” such as butyl and amyl nitrates.

“In general, the patients used more drugs than controls, but less alcohol,” Dr. Bernstein says. Researchers also found that men reported using drugs much more often than women did. After taking other factors, such as past medical history, into account, researchers found the link between cocaine and cancer.

“We saw a similar increased risk for the cancer in women using cocaine, but there were so few female drug-takers in the study that it’s impossible to draw any conclusions,” Nelson says.

First Link Between Cocaine and Cancer

This is the first time anyone has found a link between cocaine and cancer, says Dr. Bernstein. The authors speculate that cocaine may stimulate white blood cell activity and growth, thereby speeding up the propagation of chance genetic errors that could lead to cancer.

Dr. Bernstein notes, however, that the study needs to be repeated before scientists can say with any certainty whether cocaine itself triggers the disease or whether some other unknown factors play a role.

In any case, cocaine use alone cannot fully explain the steady rise in NHL cases over the last 30 years. Between 1973 and 1991, there was a 70% increase in the incidence of the disease. While some of that increase has been tied to the AIDS epidemic—HIV-positive patients face 60 times the risk of developing NHL as the general population—evidence shows that AIDS does not account for most of this trend.

A weakened immune system is known to render people at higher risk of NHL. Researchers have also found links between certain herbicides, such as 2,4-D, and NHL. Others are investigating Epstein-Barr virus.

“In many ways,” says Dr. Bernstein, “epidemiologists are just beginning to unravel the complex pattern of risk factors for this disease.” 

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
May 20, 2013
Radiotherapy Is NOT Essential to Cure Diffuse Large B-Cell Non-Hodgkin Lymphoma
ONCOLOGY,  May 15, 2013
Radiotherapy Is NOT Essential to Cure Diffuse Large B-Cell Non-Hodgkin Lymphoma
ONCOLOGY,  May 15, 2013
Making Good Results Even Better: The Evolving Role of Radiotherapy in Patients With Early Diffuse Large B-Cell Lymphoma
ONCOLOGY,  May 15, 2013
Making Good Results Even Better: The Evolving Role of Radiotherapy in Patients With Early Diffuse Large B-Cell Lymphoma
ONCOLOGY,  May 15, 2013
 
PUBLICATIONS
ONCOLOGY Journal ONCOLOGY Nurse Edition Journal Cancer Management: A Multidisciplinary Approach

ONCOLOGY

ONCOLOGY:
Nurse Edition

CANCER
MANAGEMENT
:
A Multidisciplinary
Approach

 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • Skin Lesions
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter



CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy